Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Return on Sales: 2017-2018

Historic Return on Sales for Astria Therapeutics (ATXS) over the last 1 years, with Sep 2018 value amounting to -171.18%.

  • Astria Therapeutics' Return on Sales was N/A to -171.18% in Q3 2018 from the same period last year, while for Sep 2018 it was -171.18%, marking a year-over-year change of. This contributed to the annual value of 260.46% for FY2018, which is 31525.00% up from last year.
  • As of Q3 2018, Astria Therapeutics' Return on Sales stood at -171.18%, which was down 161.41% from -65.48% recorded in Q2 2018.
  • Over the past 5 years, Astria Therapeutics' Return on Sales peaked at -65.48% during Q2 2018, and registered a low of -171.18% during Q3 2018.
  • Moreover, its 2-year median value for Return on Sales was -104.31% (2017), whereas its average is -111.32%.